|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/18 | |
| C07K 16/28 | |||
| A61K 39/00 |
| (11) | Number of the document | 2118300 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08725981.8 |
| Date of filing the European patent application | 2008-02-22 | |
| (97) | Date of publication of the European application | 2009-11-18 |
| (45) | Date of publication and mention of the grant of the patent | 2015-05-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/002392 |
| Date | 2008-02-22 |
| (87) | Number | WO 2008/103472 |
| Date | 2008-08-28 |
| (30) | Number | Date | Country code |
| 710248 | 2007-02-23 | US | |
| 697646 | 2007-04-06 | US | |
| 984721 P | 2007-11-01 | US |
| (72) |
SCHENK, Dale, B., US
MASLIAH, Eliezer, US
BUTTINI, Manuel, J., US
CHILCOTE, Tamie, J., US
ROCKENSTEIN, Edward, US
GAMES, Kate, Dora, US
|
| (73) |
The Regents of the University of California,
1111 Franklin Street, 12th Floor, Oakland, CA 94607,
US
Prothena Biosciences Limited, 25-28 North Wall Quay, Dublin 1, IE |
| (54) | PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASE |
| PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASE |